Short Interest in Revolution Medicines, Inc. (NASDAQ:RVMDW) Rises By 25.0%

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 500 shares, an increase of 25.0% from the November 15th total of 400 shares. Based on an average trading volume of 36,800 shares, the days-to-cover ratio is presently 0.0 days.

Revolution Medicines Price Performance

RVMDW stock traded down $0.01 during midday trading on Friday, hitting $0.31. 598 shares of the company’s stock were exchanged, compared to its average volume of 18,021. Revolution Medicines has a 1-year low of $0.05 and a 1-year high of $0.80. The business has a 50-day simple moving average of $0.32 and a two-hundred day simple moving average of $0.20.

Revolution Medicines Company Profile

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.